维普期刊资源整合服务平台（V6.5）

293篇 您的检索式：作者名="SAROSI I"

选中清除导出查看参考文献查看引证文献引用追踪共15页首页上一页第1页下一页末页 /15 跳转

	题名	作者	年代	出处	被引量
1	Osteoprotegerin Ligand Is a Cytokine that Regulates Osteoclast Differentiation and Activation显示文摘	D.L Lacey E Timms H.-L Tan M.J Kelley C.R Dunstan T Burgess R Elliott A Colombero G Elliott S Scully H Hsu J Sullivan N Hawkins E Davy C Capparelli A Eli Y.-X Qian S Kaufman I Sarosi V Shalhoub G Senaldi J Guo J Delaney W.J Boyle	1998	Cell1998，，2：	4
2	OPGL is a key regulator of osteoclastogenesis, lymphoctye development and lymph-node organogenesis显示文摘	Kong YY Yoshida H Sarosi I	1999	Nature1999，397，6717：	2
3	Activated T cells regulate bone loss and joint destruction in adjuvant arthritis through osteoprotegerin ligand显示文摘	Kong YY Feige U Sarosi I		0，，：	2
4	OPGL is a key regulator of osteoclastogenesis,lymphocyte development and lymph-node organogenesis显示文摘	Kong YY Yoshida H Sarosi I	1999	Nature1999，397，：	1
5	Activated T cells regulate bone loss and joint destruction in adjuvant arthritis through osteoprotegerin ligand显示文摘	Kong Y Y Feige U Sarosi I	1999	Nature1999，402，18：	1
6	RANK is the intrinsic hemato-poietic cell surface receptor that controls osteoclastogenesis and regulation of bone mass and calcium metabolism显示文摘	LI J SAROSI I YAO X Q	2000	Proc Natl Acad Sci USA2000，97，：	1
7	OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis显示文摘	Yoshida H Sarosi I	1999	Nature1999，397，6717：	1
8	Osteoprotegerirr deficient mice develop early onset osteoporosis and arterial calcification显示文摘	Bucay N Sarosi I Dunstan CR	1998	Genes Dev1998，12，9：	1
9	osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification显示文摘	Bucay N Sarosi I Dunstan C R	1998	Genes Dev1998，12，9：	1
10	Activated T cells regulate boneloss and joint destruction in adjuvant arthritis through osteopro-tegerin ligand显示文摘	Kong YY Feige U Sarosi I	1999	Nature1999，402，6759：	1
11	显示文摘	Min H Morony S Sarosi I	2000	J Exp Med2000，192，：	1
12	OPGL is a key regulator of osteoclastogenesis,lymphocyte development and lymph-node organogenesis显示文摘	Kong YY Yoshida H Sarosi I	1999	Nature1999，397，6717：	1
13	Activated T cells regulate bone loss and joint destruction in adjuvant arthritis through osteoprotegerin ligand显示文摘	Kong YY Feige U Sarosi I	1999	Nature1999，402，6759：	1
14	Activated T cells regulate bone loss and joint destruction in adjuvant arthritis through osteoprotegerin ligand显示文摘	Kong YY Feige U Sarosi I		0，，：	1
15	Osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification显示文摘	Bucay N Sarosi I Dunstan CR	1998	Genes Dev1998，12，9：	1
16	Osteoprotegerin reverses osteoporosis by inhibiting endosteal osteoclasts and prevents vascular calcification by blocking a process resembling osteoclastogenesis显示文摘	Min H Morony S Sarosi I	2000	J Exp Med2000，192，4：	1
17	RANK is the intrinsic hematopoietic cell surface receptor that controls osteoclastogenesis and regulation of bone mass and calcium metabolism显示文摘	Sarosi I Yan XQ	2000	Proc Natl Acad Sci USA2000，97，4：	1
18	OPGL is the key regulator of osteoclastogenesis,lymphocyte development and lymph - node organogenesis显示文摘	Kong YY Yoshida H Sarosi I	1999	Nature1999，397，6717：	1
19	OPGL is a key regulator of osteoclastogenesis,lymphocyte development and lymph-node organog -enesis显示文摘	Kong YY Yoshida H Sarosi I	1999	Nature1999，397，6717：	1
20	RANK is the intrinsichematopoietic cell surface receptor that controls os-teoclastogenesis and regulation of bone mass andcalcium metabolism 显示文摘	Li J Sarosi I Yan XQ	2000	Proc Natl Acad Sci USA2000，97，4：	1

返回顶部每页显示：

共15页首页上一页第1页下一页末页 /15 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示